In a video interview with Pharma’s Almanac, Kevin Sharp, EVP and Head of Sales and Operation, shares insights on Samsung Organoids, which enables clients to better model patient response in the R&D of novel molecules, and highlights our ADC facility, providing full antibody development, manufacturing, and conjugation services.
Watch the interview to learn more about the latest business updates, including expansion into research services and ADC drug product development on the horizon.
In a video interview with Pharma’s Almanac, Kevin Sharp, EVP and Head of Sales and Operation, shares insights on Samsung Organoids, which enables clients to better model patient response in the R&D of novel molecules, and highlights our ADC facility, providing full antibody development, manufacturing, and conjugation services.
Watch the interview to learn more about the latest business updates, including expansion into research services and ADC drug product development on the horizon.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article